tenk.fyi

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

LIXTNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$3.6M

29.5% YoY

EPS

$-1.59

40.2% YoY

Cash

-

FY 2024 · As of 2024-12-31